TORONTO, CANADA, October 31, 2019 – FUJIFILM VisualSonics Inc., a world leader in ultra-high frequency ultrasound and photoacoustic imaging systems and subsidiary of FUJIFILM SonoSite, Inc., and part of the Fujifilm Healthcare portfolio, celebrated twenty years of innovation in scientific research on October 29, 2019. To mark the special occasion, FUJIFILM VisualSonics hosted an open house at their Toronto based office and welcomed guests to participate in product demonstrations as well as a display showcasing the evolution of ultra-high frequency ultrasound and photoacoustic technology. Remarks and presentations were provided by FUJIFILM VisualSonics staff members and special guests.
“More than ever, researchers rely heavily on imaging tools to visualize and acquire important data to be able to succeed in their research. FUJIFILM VisualSonics has been consistently delivering the most cutting edge ultrasound and photoacoustic imaging solutions into the hands of trailblazers in scientific research since 1999,” said Andrew Needles, Director, Marketing and Product Management, FUJIFILM VisualSonics, Inc. “The desire to deliver the right tools to the researcher is what fuels the passion for the team at FUJIFILM VisualSonics.”
In the last twenty years, FUJIFILM VisualSonics has taken UHF ultrasound technology from a little known innovation to a modality that is now used worldwide in a multitude of research projects across both preclinical and clinical applications. With over 2,500 publications citing the use of a VisualSonics imaging system, Fujifilm has had a tremendous impact on translational research by allowing users to acquire valuable anatomical, functional and molecular data while visualizing the nature of a disease.
“In an industry where companies come and go over time, we are grateful to our customers who have challenged us and grown with us,” said Greg Nesbitt, Vice President, Global High Frequency, FUJIFILM VisualSonics, Inc. “Our ability to build a sustainable business ensures we are able to invest in the next generation of solutions and develop new technology to help us find new ways to support our customers’ success.”
FUJIFILM VisualSonics, Inc. has earned the trust of thousands of customers around the world and has a continuous stream of new products in its R&D pipeline. In the upcoming year, FUJIFILM VisualSonics will increase the number of workshops that are hosted in order to bring together the research community to learn, share best practices, and build relationships with the focus on ultra-high frequency ultrasound and photoacoustics.
Above: FUJIFILM VisualSonics, Inc. team members from the past and present during the 20th Anniversary celebration
Above: Andrew Needles, Director, Marketing and Product Management, FUJIFILM VisualSonics, Inc., detailing the important contributions of FUJIFILM VisualSonics, Inc. in developing cutting-edge ultrasound and photoacoustic imaging solutions for scientific research since 1999.
Above: Dr. Stuart Foster, Founder, in front of FUJIFILM VisualSonics’ flagship Vevo 3100 imaging system.To learn more about FUJIFILM VisualSonics, Inc contributions over the past 20 years, watch this video:
About Fujifilm
FUJIFILM VisualSonics, Inc., is a global leader in real time, in vivo, ultra high frequency ultrasound and photoacoustic imaging systems. With headquarters in Toronto, Canada and offices around the world, FUJIFILM VisualSonics is represented globally across an integrated sales network. FUJIFILM VisualSonics is recognized worldwide for providing cutting edge imaging technologies for the advancement of preclinical research, particularly in cardiovascular, oncology, neurobiology and developmental biology areas. With the expansion of the product portfolio to include a new clinical product, FUJIFILM VisualSonics now broadens their range of imaging technologies across both preclinical and clinical markets. FUJIFILM VisualSonics is a subsidiary of FUJIFILM SonoSite, Inc. and a part of FUJIFILM Holdings Corporation. For more information, please visit: www.visualsonics.com.
FUJIFILM SonoSite, Inc. is the innovator and world leader in bedside and point-of-care ultrasound, and an industry leader in ultra high-frequency micro-ultrasound technology. Headquartered near Seattle, the company is represented by a global distribution network in over 100 countries. SonoSite’s portable, compact systems are expanding the use of ultrasound across the clinical spectrum by cost-effectively bringing high-performance ultrasound to the point of patient care. For more information, please visit www.sonosite.com.
FUJIFILM Holdings Corporation, Tokyo, Japan, brings cutting edge solutions to a broad range of global industries by leveraging its depth of knowledge and fundamental technologies developed in its relentless pursuit of innovation. Its proprietary core technologies contribute to the various fields including healthcare, graphic systems, highly functional materials, optical devices, digital imaging and document products. These products and services are based on its extensive portfolio of chemical, mechanical, optical, electronic and imaging technologies. For the year ended March 31, 2019, the company had global revenues of $22 billion, at an exchange rate of 111 yen to the dollar. Fujifilm is committed to responsible environmental stewardship and good corporate citizenship. For more information, please visit: www.fujifilmholdings.com.
All product and company names herein may be trademarks of their registered owners.
CONTACT:
Christine Jackman
Fujifilm
(914) 789-8523
christine.jackman@fujifilm.com